Koyfin Home > Directory > Health Care > Kindred Biosciences > Preferred Equity

Kindred Biosciences Preferred Equity Chart (KIN)

Kindred Biosciences annual/quarterly Preferred Equity from 2012 to 2013.
  • Kindred Biosciences Preferred Equity for the quarter ending June 06, 2013 was $4m
  • Kindred Biosciences Preferred Equity for the last 12 months ending December 12, 2012 was $1m
Other Balance Sheet Metrics:
  • Kindred Biosciences Total Assets for the quarter ending September 09, 2018 was $113m a 19.90% increase of 23m year over year
  • Kindred Biosciences Other Liabilities for the quarter ending December 12, 2018 was $0m a -18.09% decrease of 0m year over year
  • Kindred Biosciences Total Equity for the quarter ending September 09, 2018 was $104m a 18.91% increase of 20m year over year
View Chart On Koyfin

Quarterly KIN Preferred Equity Data

06/2013$4m
03/2013$1m
12/2012$1m

Annual KIN Preferred Equity Data

2012$1m